{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-21-002832","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2021-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.707136+00:00","generated_at":"2026-06-28T13:52:40.541917+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Outset Medical Q3 revenue $26.3M, up 91% YoY; raises 2021 guidance to $99-101M","bullets":["Revenue $26.3M (+91.3% YoY); product revenue $21.8M (+101.9% YoY).","Net loss $30.5M ($0.65 loss per share); non-GAAP net loss $27.6M ($0.59).","Gross margin improved to 11.2% from (37.3%) a year ago; product gross margin turned positive at 5.9%.","FY2021 revenue guidance raised to $99-101M from prior $97-100M.","Received favorable TPNIES decision for Tablo; cash balance $406.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-21-002832","json":"https://secwatch.observer/filing/0000950170-21-002832.json","markdown":"https://secwatch.observer/filing/0000950170-21-002832.md","text":"https://secwatch.observer/filing/0000950170-21-002832.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000095017021002832/0000950170-21-002832-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000095017021002832/om-20211103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T13:52:40.541917+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}